Filing Details
- Accession Number:
- 0001179110-20-009219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-21 16:12:23
- Reporting Period:
- 2020-08-20
- Accepted Time:
- 2020-08-21 16:12:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1650664 | Editas Medicine Inc. | EDIT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405692 | Cynthia Collins | C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-08-20 | 1,976 | $36.66 | 45,022 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 19, 2020. The sale does not represent a discretionary trade by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $36.44 to $36.66. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.